DrugPatentWatch Database Preview
Tafenoquine succinate - Generic Drug Details
» See Plans and Pricing
What are the generic drug sources for tafenoquine succinate and what is the scope of patent protection?
Tafenoquine succinate
is the generic ingredient in two branded drugs marketed by 60 Degrees Pharms and Glaxosmithkline, and is included in two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.Tafenoquine succinate has seven patent family members in seven countries.
One supplier is listed for this compound.
Summary for tafenoquine succinate
| International Patents: | 7 |
| US Patents: | 1 |
| Tradenames: | 2 |
| Applicants: | 2 |
| NDAs: | 2 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 18 |
| Patent Applications: | 33 |
| DailyMed Link: | tafenoquine succinate at DailyMed |
US Patents and Regulatory Information for tafenoquine succinate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | KRINTAFEL | tafenoquine succinate | TABLET;ORAL | 210795-001 | Jul 20, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| 60 Degrees Pharms | ARAKODA | tafenoquine succinate | TABLET;ORAL | 210607-001 | Aug 8, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| 60 Degrees Pharms | ARAKODA | tafenoquine succinate | TABLET;ORAL | 210607-001 | Aug 8, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| 60 Degrees Pharms | ARAKODA | tafenoquine succinate | TABLET;ORAL | 210607-001 | Aug 8, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Glaxosmithkline | KRINTAFEL | tafenoquine succinate | TABLET;ORAL | 210795-001 | Jul 20, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for tafenoquine succinate
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2968694 | Start Trial |
| China | 107683278 | Start Trial |
| Singapore | 11201704154Q | Start Trial |
| Hong Kong | 1243704 | Start Trial |
| Australia | 2015358566 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
